INFERIOR VENA CAVA (IVC) FILTER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In May 2022, Argon Medical announced a partnership with Terumo India, a global leader in medical technology, to bring their products to the Indian market and offer comprehensive solutions for interventional radiology, vascular surgery, interventional cardiology, and clinical oncology
• In December 2021, the U.S. Food and Drug Administration had authorized the marketing of the Philips CavaClear Laser Sheath, the first laser-based device for removing inferior vena cava (IVC) filters. This device is designed to assist in detaching IVC filters, which are used to capture blood clots, when previous removal methods have failed.
• In July 2021, Royal Philips announced that the FDA had granted Breakthrough Device Designation for its laser-assisted device to remove inferior vena cava (IVC) filters when previous methods fail. IVC filters, used to prevent blood clots from reaching the heart or lungs, can pose long-term risks, prompting the FDA to recommend their removal when no longer needed.

*Definition- Global inferior vena cava (IVC) filter market consists of medical devices that are implanted in the inferior vena cava to prevent life-threatening pulmonary embolisms. IVC filters trap blood clots before they can reach the lungs. Key types include retrievable IVC filters and permanent IVC filters. The market has witnessed growth due to rising incidence of deep vein thrombosis and pulmonary embolism.